Susceptibility Polymorphism in the Promoter Region of IL-4 and IL-13 in Individuals with Periodontitis: A Systematic Review

Rafaella Ugrin de Oliveira Silva; Maria Tereza de Moraes Longhi; François Isnaldo Dias Caldeira; Renata Cristina Lima Silva; Rodrigo Alvitos; Leandro Araújo Fernandes; Catarina Pereira Monteiro Lima; Ticiana Sidorenko de Oliveira Capote

Authors

Rafaella Ugrin de Oliveira Silva
Maria Tereza de Moraes Longhi
François Isnaldo Dias Caldeira
Renata Cristina Lima Silva
Rodrigo Alvitos
Leandro Araújo Fernandes
Catarina Pereira Monteiro Lima
Ticiana Sidorenko de Oliveira Capote

Keywords:

Polymorphism, Genetic, Periodontitis, Review

Abstract

Objective: To understand the susceptibility to single nucleotide polymorphisms in the promoter region of Interleukin-4 (IL-4) and Interleukin-13 (IL-13) in patients with and without periodontal disease. Thus, a systematic review of available studies on the subject was performed. Material and Methods: A protocol was conducted for registration in the International Prospective Register of Systematic Reviews (PROSPERO) under CRD42021246646. For this search, studies were selected from the Scopus, Web of Science, Virtual Health Library, Embase, Cochrane Library, and PubMed databases. The selection criteria consisted of case-control and cohort studies published in English that had data on IL-4 and IL-13 genetic polymorphisms in patients with and without periodontal disease in the same study. The obtained studies were managed by EndNote Program™ X7 version and the Rayyan Platform. Regarding the risk of bias, we used the Newcastle-Ottawa Scale, which classified the studies using high-quality methodology. Results: After the selection process, three studies presented the eligibility criteria. No relation between IL-13 and susceptibility to periodontal disease was found. IL-4 gene (IL-4 -590C/T; IL-4-34C/T; rs2243248) was associated with susceptibility to the development of periodontitis. Conclusion: An association between IL-4 and the susceptibility of periodontitis was verified. Further case-control studies are needed to create more concrete conclusions on the subject.

References

Caldeira FID, Hidalgo MAR, De Carli Dias ML, Scarel-Caminaga RM, Pigossi SC. Systematic review of ratios between disease /health periodontitis modulators and meta-analysis of their levels in gingival tissue and biological fluids. Arch Oral Biol 2021; 127:105147. https://doi.org/10.1016/j.archoralbio.2021.105147

Kowalski J, Nowak M, Gorski B, Gorska R. What has immunology brought to periodontal disease in recent years? Arch Immunol Ther Exp 2022; 70(1):26. https://doi.org/10.1007/s00005-022-00662-9

Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers 2017; 3:17038. https://doi.org/10.1038/nrdp.2017.38

Gonzales JR, Mann M, Stelzig J, Bödeker RH, Meyle J. Single-nucleotide polymorphisms in the IL-4 and IL-13 promoter region in aggressive periodontitis. J Clin Periodontol 2007; 34(6):473-479. https://doi.org/10.1111/j.1600-051X.2007.01086.x

Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol 2018; 89(Suppl 1):S173-s182. https://doi.org/10.1002/jper.17-0721

Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999; 4(1):1-6. https://doi.org/10.1902/annals.1999.4.1.1

Zhang W, Xu P, Chen Z, Cheng Y, Li X, Mao Q. IL-13 -1112 polymorphism and periodontitis susceptibility: A meta-analysis. BMC Oral Health 2018; 18(1):21. https://doi.org/10.1186/s12903-018-0481-y

Caton JG, Armitage G, Berglundh T, Chapple ILC, Jepsen S, Kornman KS, et al. A new classification scheme for periodontal and peri-implant diseases and conditions - Introduction and key changes from the 1999 classification. J Clin Periodontol 2018; 45(Suppl 20):S1-S8. https://doi.org/10.1111/jcpe.12935

Isola G, Santonocito S, Lupi SM, Polizzi A, Sclafani R, Patini R, et al. Periodontal health and disease in the context of systemic diseases. Mediators Inflamm 2023; 2023:9720947. https://doi.org/10.1155/2023/9720947

Yan Y, Weng H, Shen ZH, Wu L, Zeng XT. Association between interleukin-4 gene -590 c/t, -33 c/t, and 70-base-pair polymorphisms and periodontitis susceptibility: A meta-analysis. J Periodontol 2014; 85(11):e354-362. https://doi.org/10.1902/jop.2014.140317

Hodge P, Michalowicz B. Genetic predisposition to periodontitis in children and young adults. Periodontol 2000 2001; 26:113-134. https://doi.org/10.1034/j.1600-0757.2001.2260106.x

Reichert S, Stein JM, Klapproth J, Zimmermann U, Reichert Y, Gläser C, et al. The genetic impact of the Q551R interleukin-4 receptor alpha polymorphism for aggressive or chronic periodontitis and the occurrence of periodontopathic bacteria. Arch Oral Biol 2011; 56(12):1485-1493. https://doi.org/10.1016/j.archoralbio.2011.06.003

Anovazzi G, Kim YJ, Viana AC, Curtis KM, Orrico SR, Cirelli JA, et al. Polymorphisms and haplotypes in the interleukin-4 gene are associated with chronic periodontitis in a Brazilian population. J Periodontol 2010; 81(3):392-402. https://doi.org/10.1902/jop.2009.090392

Shapira L, van Dyke TE, Hart TC. A localized absence of interleukin-4 triggers periodontal disease activity: A novel hypothesis. Med hypotheses 1992; 39(4):319-322. https://doi.org/10.1016/0306-9877(92)90056-i

Chen D, Zhang TL, Wang X. Association between polymorphisms in interleukins 4 and 13 genes and chronic periodontitis in a Han Chinese Population. BioMed Res Int 2016; 2016:8389020. https://doi.org/10.1155/2016/8389020

Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, Klinnert M, et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995; 25(Suppl 2):74-78; discussion 95-96. https://doi.org/10.1111/j.1365-2222.1995.tb00428.x

Wu YM, Chuang HL, Ho YP, Ho KY, Tsai CC. Investigation of interleukin-13 gene polymorphisms in individuals with chronic and generalized aggressive periodontitis in a Taiwanese (Chinese) population. J Periodontal Res 2010; 45(5):695-701. https://doi.org/10.1111/j.1600-0765.2010.01287.x

Gorgun EP, Toker H, Tas A, Alpan AL, Sari I, Silig Y. IL-13 gene polymorphisms (-1112 C/T and -1512 A/C) in patients with chronic and aggressive periodontitis: Effects on GCF and outcome of periodontal therapy. Niger J Clin Pract 2021; 24(7):965-972. https://doi.org/10.4103/njcp.njcp_487_19

Kozak M, Dabrowska-Zamojcin E, Mazurek-Mochol M, Pawlik A. Cytokines and their genetic polymorphisms related to periodontal disease. J Clin Med 2020; 9(12). https://doi.org/10.3390/jcm9124045

Majumder P, Panda SK, Ghosh S, Dey SK. Interleukin gene polymorphisms in chronic periodontitis: A case-control study in the Indian population. Arch Oral Biol 2019; 101:156-164. https://doi.org/10.1016/j.archoralbio.2019.03.015

de Waal Malefyt R, Figdor CG, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol 1993; 151(11):6370-6381.

Zhang X, Tan R, Lam WC, Yao L, Wang X, Cheng CW, et al. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) extension for Chinese herbal medicines 2020 (PRISMA-CHM 2020). Am J Chin Med 2020; 48(6):1279-1313. https://doi.org/10.1142/S0192415X20500639

Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Oxford; 2000.

Zheng Y, Chai L, Fan Y, Song YQ, Zee KY, Tu WW, et al. Th2 cell regulatory and effector molecules single nucleotide polymorphisms and periodontitis. J Leukoc Biol 2020; 108(5):1641-1654. https://doi.org/10.1002/JLB.4MA0720-698RR

Dutra WO, Moreira PR, Souza PE, Gollob KJ, Gomez RS. Implications of cytokine gene polymorphisms on the orchestration of the immune response: lessons learned from oral diseases. Cytokine Growth Factor Rev 2009; 20(3):223-232. https://doi.org/10.1016/j.cytogfr.2009.05.005

Nakajima T, Yamazaki K, Cullinan MP, Gemmell E, Seymour GJ. T-cell antigen specificity in humans following stimulation with Porphyromonas gingivalis. Arch Oral Biol 1999; 44(12):1045-1053. https://doi.org/10.1016/s0003-9969(99)00094-1

Liu X, Li H. A Systematic review and meta-analysis on multiple cytokine gene polymorphisms in the pathogenesis of periodontitis. Front Immunol 2021; 12:713198. https://doi.org/10.3389/fimmu.2021.713198

Reichert S, Stein JM, Klapproth J, Zimmermann U, Reichert Y, Glaser C, et al. The genetic impact of the Q551R interleukin-4 receptor alpha polymorphism for aggressive or chronic periodontitis and the occurrence of periodontopathic bacteria. Arch Oral Biol 2011; 56(12):1485-1493. https://doi.org/10.1016/j.archoralbio.2011.06.003

Yucesoy B, Kashon ML, Luster MI. Cytokine polymorphisms in chronic inflammatory diseases with reference to occupational diseases. Curr Mol Med 2003; 3(1):39-48. https://doi.org/10.2174/1566524033361582

Karuppanan SK, Sekar S, Devi SS. Role of Interleukin-33 in immunity and periodontal inflammation-A literature review. JCDR 2018; 12(7):ZE08-ZE10. https://doi.org/10.7860/JCDR/2018/32737.11788

Isacco CG, Ballini A, De Vito D, Nguyen KCD, Cantore S, Bottalico L, et al. Rebalancing the oral microbiota as an efficient tool in endocrine, metabolic and immune disorders. Endocr Metab Immune Disord Drug Targets 2021; 21(5):777-784. https://doi.org/10.2174/1871530320666200729142504

Gonzales JR, Gröger S, Haley G, Bödeker RH, Meyle J. Production of Interleukin‐13 is influenced by the Interleukin‐4− 34TT and− 590TT genotype in patients with aggressive periodontitis. Scand J ImmunoL 2011; 73(2):128-134. https://doi.org/10.1111/j.1365-3083.2010.02482.x

Dong C, Li-ming W, Jie Z. Gene polymorphism and linkage disequilibrium of IL-13 and IL-4 in Chinese Han population with chronic periodontitis. J Shanghai Jiaotong Univ 2013; 33(6):796. https://doi.org/10.3969/j.issn.1674-8115.2013.06.020 [In Chinese].

Mitchison NA. Polymorphism in regulatory gene sequences. Genome Biol 2001; 2(1): comment2001.1–comment2001.6. https://doi.org/10.1186/gb-2000-2-1-comment2001

Gonzales JR, Mann M, Stelzig J, Bodeker RH, Meyle J. Single-nucleotide polymorphisms in the IL-4 and IL-13 promoter region in aggressive periodontitis. J Clin Periodontol 2007; 34(6):473-479. https://doi.org/10.1111/j.1600-051X.2007.01086.x

Stabholz A, Soskolne WA, Shapira L. Genetic and environmental risk factors for chronic periodontitis and aggressive periodontitis. Periodontol 2000 2010; 53:138-153. https://doi.org/10.1111/j.1600-0757.2010.00340.x

Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Clin Periodontol 2018; 45(Suppl 20):S149-S161. https://doi.org/10.1111/jcpe.12945

Barros SP, Fahimipour F, Tarran R, Kim S, Scarel-Caminaga RM, Justice A, et al. Epigenetic reprogramming in periodontal disease: Dynamic crosstalk with potential impact in oncogenesis. Periodontol 2000 2020; 82(1):157-172. https://doi.org/10.1111/prd.12322

Armitage GC. Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000 2004; 34:9-21. https://doi.org/10.1046/j.0906-6713.2002.003421.x

Papapanou PN, Neiderud AM, Papadimitriou A, Sandros J, Dahlen G. "Checkerboard" assessments of periodontal microbiota and serum antibody responses: A case-control study. J Periodontol 2000; 71(6):885-897. https://doi.org/10.1902/jop.2000.71.6.885

Romagnani S. The Th1/Th2 paradigm. Immunol today 1997; 18(6):263-266. https://doi.org/10.1016/s0167-5699(97)80019-9

Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994; 76(2):241-251. https://doi.org/10.1016/0092-8674(94)90332-8

Fujihashi K, Yamamoto M, Hiroi T, Bamberg TV, McGhee JR, Kiyono H. Selected Th1 and Th2 cytokine mRNA expression by CD4(+) T cells isolated from inflamed human gingival tissues. Clin Exp Immunol 1996; 103(3):422-428. https://doi.org/10.1111/j.1365-2249.1996.tb08297.x

Cekici A, Kantarci A, Hasturk H, Van Dyke TE. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000 2014; 64(1):57-80. https://doi.org/10.1111/prd.12002

Jia XW, Yuan YD, Yao ZX, Wu CJ, Chen X, Chen XH, et al. Association between IL-4 and IL-4R polymorphisms and periodontitis: A meta-analysis. Dis Markers 2017; 2017:8021279. https://doi.org/10.1155/2017/8021279

Kasaian MT, Miller DK. IL-13 as a therapeutic target for respiratory disease. Biochem Pharmacol 2008; 76(2):147-155. https://doi.org/10.1016/j.bcp.2008.04.002

McKenzie AN, Culpepper JA, de Waal Malefyt R, Briere F, Punnonen J, Aversa G, et al. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 1993; 90(8):3735-3739. https://doi.org/10.1073/pnas.90.8.3735

Suarez LJ, Ocampo AM, Duenas RE, Rodriguez A. Relative proportions of T-cell subpopulations and cytokines that mediate and regulate the adaptive immune response in patients with aggressive periodontitis. J Periodontol 2004; 75(9):1209-1215. https://doi.org/10.1902/jop.2004.75.9.1209